Systemic lupus erythematosus (SLE) is the prototypic systemic autoimmune disease that has the potential tocause serious morbidity and early mortality and is responsible for tremendous costs to affected individualsand society. A striking feature of SLE is variation in health outcomes. In particular, substantial researchdocuments ethnic disparities in SLE risk and severity. In spite of the magnitude of variation in SLE healthoutcomes, and the potential importance for patients, physicians and society, many questions remain aboutthe underlying causes. For example, it remains unclear whether ethnic disparities in SLE outcomes reflectprimarily individual, social, environmental or genetic variation in risk or interactions among these factors.Our lack of understanding is at least partially due to the challenges of assembling a sufficiently large anddiverse cohort of SLE patients, measuring the full range of potentially important risk factors, and accuratelyassessing health outcomes. The current proposal represents a unique combination of clinical andinvestigative resources that has been developed to address this critically important issue. Specifically, wewill: 1) determine the relative contributions of demographic, socioeconomic, psychosocial, behavioral andgenetic factors to health outcomes in SLE; and 2) characterize changes in health outcomes over time andthe contribution of these explanatory factors to temporal changes in outcome. A primary focus of this projectwill be the relationship of ethnicity to SLE outcomes, and in particular understanding the roles of geneticsand other factors (e.g., socioeconomic, psychosocial, etc.) as mediators of ethnic disparities in outcome.Our study population will be approximately 1,000 SLE patients enrolled in the Lupus Outcome Study. Wewill use validated instruments to assess the following outcomes: general health status, disease activity andcumulative damage. A unique feature of the current proposal is the depth and breadth of potentiallyimportant explanatory factors that will be considered. In addition to traditional risk factors, these includenovel measures of community characteristics obtained through 'geocoding' to small geographic areas andancestry informative genetic markers. Due to the size and scope of this project, in conjunction with the richresources and expertise of the MCRC, this project should substantially increase our understanding of healthdisparities in SLE and their underlying causes and guide efforts to remedy these disparities.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Comprehensive Center (P60)
Project #
5P60AR053308-03
Application #
7612004
Study Section
Special Emphasis Panel (ZAR1)
Project Start
2008-04-01
Project End
2011-03-31
Budget Start
2008-04-01
Budget End
2009-03-31
Support Year
3
Fiscal Year
2008
Total Cost
$141,360
Indirect Cost
Name
University of California San Francisco
Department
Type
DUNS #
094878337
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Patel, Zubin; Lu, Xiaoming; Miller, Daniel et al. (2018) A plausibly causal functional lupus-associated risk variant in the STAT1-STAT4 locus. Hum Mol Genet :
Leonard, Dag; Svenungsson, Elisabet; Dahlqvist, Johanna et al. (2018) Novel gene variants associated with cardiovascular disease in systemic lupus erythematosus and rheumatoid arthritis. Ann Rheum Dis 77:1063-1069
Heshin-Bekenstein, Merav; Perl, Liat; Hersh, Aimee O et al. (2018) Final adult height of patients with childhood-onset systemic lupus erythematosus: a cross sectional analysis. Pediatr Rheumatol Online J 16:30
Jafri, Kashif; Ogdie, Alexis; Qasim, Atif et al. (2018) Discordance of the Framingham cardiovascular risk score and the 2013 American College of Cardiology/American Heart Association risk score in systemic lupus erythematosus and rheumatoid arthritis. Clin Rheumatol 37:467-474
Mccormick, Natalie; Trupin, Laura; Yelin, Edward H et al. (2018) Socioeconomic Predictors of Incident Depression in Systemic Lupus Erythematosus. Arthritis Care Res (Hoboken) 70:104-113
Lanata, Cristina M; Nititham, Joanne; Taylor, Kimberly E et al. (2018) Genetic contributions to lupus nephritis in a multi-ethnic cohort of systemic lupus erythematous patients. PLoS One 13:e0199003
Azizoddin, Desiree R; Jolly, Meenakshi; Arora, Shilpa et al. (2018) Patient Reported Outcomes Predict Mortality in Lupus. Arthritis Care Res (Hoboken) :
Yelin, Edward; Trupin, Laura; Bunde, Jared et al. (2018) Poverty, Neighborhoods, Persistent Stress, and SLE Outcomes:A Qualitative Study of the Patients' Perspective. Arthritis Care Res (Hoboken) :
Wysham, Katherine D; Shoback, Dolores M; Imboden Jr, John B et al. (2018) Association of High Anti-Cyclic Citrullinated Peptide Seropositivity and Lean Mass Index With Low Bone Mineral Density in Rheumatoid Arthritis. Arthritis Care Res (Hoboken) 70:961-969
Barton, Jennifer L; Hulen, Elizabeth; Schue, Allison et al. (2018) Experience and Context Shape Patient and Clinician Goals For Treatment of Rheumatoid Arthritis: A Qualitative Study. Arthritis Care Res (Hoboken) 70:1614-1620

Showing the most recent 10 out of 199 publications